Research Ready: The Physician's Guide into Clinical Research
Free preview

Start here

Welcome. This program exists because almost nobody teaches physicians how industry clinical research works or how to take part in it. We learned by building four sites ourselves, and by watching hundreds of other sites succeed and fail through Quri.

One thing to hold onto through the fundamentals: getting involved in research does not mean starting a company. There are two ways in. You can bring research into your own practice: the smallest real site is one physician serving as Principal Investigator and one coordinator, often a nurse or medical assistant already on your staff, using one or two rooms you already have, seeing patients already in your panel. Or you can partner with an established local research site that already has the staff, infrastructure and sponsor relationships, while you contribute your clinical expertise and your patients. Either way, you earn sponsor revenue and give your patients access to treatments they cannot otherwise get. Anything larger is optional and comes later, if you want it. The work fits inside what a physician and a practice already do, which is why sponsors want you.

Here is the path. Modules 1 and 2 give you the foundation: what a trial is and how the money works. Module 3 is a fit assessment that scores your practice and points you to one of two routes: building a research arm inside your practice, or working with a site that already runs research. Modules 4 through 8 then walk through both: setting up your own site, working with an existing one, landing your first trial, running it well, and your 90-day plan. Take every module in order; each one builds on the last.

Every new term is defined in a callout box the first time it appears, and each module ends with a glossary and one action step. Templates are downloadable inside the lesson that uses them. Quri, the site-connection service and kick-off consulting are in the menu whenever you want them; none is required to finish the program.

Industry vs academic research

Most physicians met research in training, at an academic medical center, where a faculty member wrote a grant, designed a study and published a paper. That is investigator-initiated research: the physician is the sponsor, the funding comes from the NIH or a foundation, and the goal is a publication.

Key termClinical trialA research study in which volunteers receive an intervention (a drug, device or procedure) under a predefined plan so its safety and effectiveness can be measured. Also called a clinical study.
Key termInvestigator-initiated trial (IIT)A study designed and sponsored by a physician or institution rather than a company. Funded by grants; governed by academic goals.
Key termAcademic medical center (AMC)A teaching hospital or university health system that conducts research, much of it investigator-initiated, and also participates in industry trials.

Industry-sponsored research is different in every way that matters to a practice. The sponsor designs the protocol, pays the site per patient and per procedure, supplies the drug, and needs many sites to enroll quickly. The site's job is execution: find the right patients, follow the protocol, record clean data. There is no grant to write and no paper to publish, although investigators are often listed as authors on the resulting publications.

Put simply, an industry trial is a company testing its own product in patients, at many sites at once, so it can win approval to sell it. The company pays every site for the work, and that payment is what makes research a business for a practice. The next lesson explains why these trials exist and why they need physicians like you.

Key termIndustry-sponsored trialA clinical trial designed, funded and run by a pharmaceutical, biotech or medical-device company to win FDA approval for its product. The company (the sponsor) pays each participating site per patient and per procedure. This program is about industry trials only.
Industry-sponsoredInvestigator-initiated / academic
Who designs itSponsor (pharma, biotech, device)Physician or institution
Who paysSponsor, per patient and per procedureGrants (NIH, foundations)
Site's jobExecute the protocol, enroll, report dataDesign, fund, run and publish
GoalFDA approval and marketPublication, scientific knowledge
Revenue to a practiceYes, at negotiated ratesRarely; grants cover costs
This programYesNo

Hospitals and AMCs also run industry trials, and they are your competition for some studies. Their advantage is reputation; their disadvantage is speed. A sponsor that needs a site to start in 60 days and enroll 12 patients in six months will often pick a well-run private practice over a university that takes nine months to sign a contract.

Intro to industry trials

Before a pharmaceutical, biotech or medical-device company can sell a product in the US, it must prove to the FDA that the product is safe and effective. The only accepted proof is data from clinical trials in human patients. No trials, no approval, no product.

Key termFDA (Food and Drug Administration)The US agency that approves drugs and devices for sale based on trial data.

The company that develops the product and pays for the trial is called the sponsor. A large sponsor may run dozens of trials at once; a small biotech may run one, with its entire future depending on it.

Key termSponsorThe company or organization that initiates, funds and is legally responsible for a trial. In industry research, a pharma, biotech or device company.

Sponsors do not run trials in their own buildings. They have no patients. They need physicians who see the right patients every day, in the community where those patients live. That is where research sites, and physicians like you, come in.

Key termClinical research siteThe physical location and organization where a trial is conducted with patients: a private practice, a dedicated research office, a hospital.

At the center of every site is one physician: the Principal Investigator. When a sponsor contracts your practice to run a trial, you sign a statement with the FDA making you personally responsible for how the study is conducted at your site: that every participant gave informed consent, that the protocol is followed, that safety is watched and reported, and that the records are accurate. You do not do all the work. You delegate visits, data entry and paperwork to a Clinical Research Coordinator, and you can share the medical work with Sub-Investigators, but the responsibility stays with you. Later lessons cover what that means task by task and list every responsibility across a trial.

Key termPrincipal Investigator (PI)The physician responsible for a trial at a site: for participant safety, protocol adherence, data integrity and supervision of everyone working on the study. Sponsors require an MD or DO. Named on Form FDA 1572. In an embedded site, the PI is usually the practice owner.
Key termSub-Investigator (Sub-I)A physician, nurse practitioner or physician assistant to whom the PI delegates medical tasks on a study (exams, eligibility assessments, adverse-event evaluation). Listed on the 1572 and supervised by the PI.
Key termClinical Research Coordinator (CRC)The staff member who runs the trial day to day under the PI: recruiting and consenting participants, conducting visits, collecting data and managing documents. Often a nurse or medical assistant trained into the role.
Example
•

Sourabh Pharmaceuticals has developed Sourempic, a weight-loss drug.

•

It works in the lab and in early studies.

•

To sell it, Sourabh needs data from hundreds of patients with obesity, treated and followed for months.

•

Those patients see endocrinologists, family physicians and cardiologists in private practices.

•

Sourabh will pay those practices to run the trial.

Why Physicians get into Research

Every clinical trial has a sponsor with a drug and a protocol, a CRO managing it, an ethics board protecting the participant, and a site where the study meets a patient. Every one of those trials also needs a licensed physician to run it at the site, with patients who trust that physician enough to say yes. Sponsors cannot manufacture either. They have the drug, the money and the protocol, and they are short of the two things you already have: a medical license and a panel of patients who know you.

There is a potentially significant line of business sitting adjacent to what you already do every day.

That is why physicians get invited into research, and why, once they see it from the inside, many decide it belongs in their practice. There are three reasons, and the rest of this module is a lesson on each.

Reason 1

An additional income stream that does not depend on a payer

Research revenue comes from the sponsor, not from insurance. It pays whether the patient's plan would have covered the care or not.

How you get paid

  • —No payer in the middle. No prior authorization, no fee schedule cut, no collections.
  • —Every unit of work is priced. A negotiated amount for every visit, every procedure and every hour of investigator time.
  • —Fixed fees on top. Startup fees and overhead, paid alongside the per-visit amounts.

It is per-patient revenue, and it scales

A study budget is written per patient. Each patient you enroll carries the full schedule of visit and procedure payments for that study, so revenue grows with enrollment:

  • —One more patient in a study is one more full set of visit payments.
  • —One more study running at the same time adds another group of patients on top.
  • —The fixed costs don't grow at the same rate. The same physician, coordinator and rooms support more patients and more studies, which is why the margin improves as you scale.

What the next three lessons show

  • —Lesson 2: a real budget, line by line.
  • —Lesson 3: what one study is worth on each path, for a practice that runs the study itself and for a physician who does the investigator work at someone else's site with no costs at all.
  • —Lesson 4: how that scales, for a practice with several studies running and for a physician who is investigator on several studies across a couple of sites with no payroll and no lease.

How far physicians take it

  • —Side arm: one study at a time, one afternoon a week.
  • —Practice revenue line: a coordinator and a few studies at once.
  • —Dedicated site: built and run as a business.
  • —Full time: owner-investigator of a site that runs ten or more studies, or a salaried full-time principal investigator for a site network that needs physicians more than it needs anything else.

Every one of those started with the first study.

That's the end of the free preview.

The full program runs 8 modules and 64 lessons: your fit assessment, setting up or joining a site, landing your first trial, running it well and your 90-day plan, with downloadable templates.

Early Cohort Special Pricing
$999Regular price $2,000

Limited early-cohort pricing, expiring soon. After that the program is $2,000.


Want to talk it through first?Book a call

Already enrolled? Sign in